Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK–mTOR Interplay
Huan Chen, Da Tran, Hsiu Chiung Yang, Sven Nylander, Yochai Birnbaum, Yumei Ye
Dive into the research topics of 'Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK–mTOR Interplay'. Together they form a unique fingerprint.